Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 3/2000

Content (11 Articles)

ORIGINAL ARTICLE

Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents

Gabriel F. Eilon, Jirong Gu, Lewis M. Slater, Kaoru Hara, John W. Jacobs

ORIGINAL ARTICLE

Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates

Katherine E. Warren, Mahendra C. Patel, Cynthia M. McCully, Luis M. Montuenga, Frank M. Balis

ORIGINAL ARTICLE

Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion

H. Rosing, V. Lustig, L.J.C. van Warmerdam, M. T. Huizing, W.W. ten Bokkel Huinink, J. H. M. Schellens, S. Rodenhuis, A. Bult, J. H. Beijnen

ORIGINAL ARTICLE

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

Kazutake Seki, Hideshi Yoshikawa, Kazuhiko Shiiki, Yoshiki Hamada, Noriya Akamatsu, Kachio Tasaka

ORIGINAL ARTICLE

Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts

Patrick W. Vincent, Alex J. Bridges, Donald J. Dykes, David W. Fry, Wilber R. Leopold, Sandra J. Patmore, Billy J. Roberts, Steven Rose, Veronika Sherwood, Hairong Zhou, William L. Elliott

ORIGINAL ARTICLE

Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer – effect of sequence

Emil Frei III, Gulshan Ara, Beverly Teicher, Craig Bunnell, Paul Richardson, Catherine Wheeler, Kenneth Tew, Anthony Elias

ORIGINAL ARTICLE

Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil

Peter Gwilt, Margaret Tempero, Alton Kremer, Mary Connolly, Cliff Ding

ORIGINAL ARTICLE

Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration

Frank M. Balis, Susan M. Blaney, Cynthia L. McCully, Robert F. Murphy, David G. Poplack, John D. Bacher

ORIGINAL ARTICLE

Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G2 arrest

Carleton B. Jones, Mark K. Clements, Safia Wasi, Sayed S. Daoud

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine